Mirae Asset Global Etfs Holdings Ltd. Erasca, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.4 Billion
- Q1 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Erasca, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 108,788 shares of ERAS stock, worth $151,215. This represents 0.0% of its overall portfolio holdings.
Number of Shares
108,788
Previous 112,565
3.36%
Holding current value
$151,215
Previous $282,000
47.16%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ERAS
# of Institutions
162Shares Held
222MCall Options Held
20.6KPut Options Held
5.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA22.6MShares$31.4 Million1.95% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD17.3MShares$24 Million0.02% of portfolio
-
Vr Adviser, LLC New York, NY16.2MShares$22.5 Million5.36% of portfolio
-
Logos Global Management LP San Francisco, CA13MShares$18.1 Million3.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.7MShares$17.7 Million0.0% of portfolio
About Erasca, Inc.
- Ticker ERAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 122,147,000
- Market Cap $170M
- Description
- Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...